pMEDS
(Plasmid
#236568)
-
PurposeIntroduces a multiple expression and dual selection (MEDS) system to use alongside CRISPR for applications such as gene editing.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 236568 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepMA-RQ
- Backbone size w/o insert (bp) 1357
- Total vector size (bp) 5683
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418) ; cytosine deaminase/uracil phosphoribosyltransferase (select with 5-FC)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert nameCD/UPRT (negative selection)
-
Alt namecytosine deaminase/uracil phosphoribosyltransferase (CD/UPRT)
-
Insert Size (bp)1125
-
Tag
/ Fusion Protein
- 3x Myc
Gene/Insert 2
-
Gene/Insert nameNPT II (positive selection)
-
Alt nameNeomycin Phosphotransferase II
-
Insert Size (bp)792
-
Tag
/ Fusion Protein
- FLAG
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pMEDS was a gift from Shannon Moonah (Addgene plasmid # 236568 ; http://n2t.net/addgene:236568 ; RRID:Addgene_236568) -
For your References section:
CRISPR genome editing using a combined positive and negative selection system. Sharma I, Hall K, Moonah S. PLoS One. 2025 May 6;20(5):e0321881. doi: 10.1371/journal.pone.0321881. eCollection 2025. 10.1371/journal.pone.0321881 PubMed 40327602